Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Quartesian has announced a partnership with Amyndas for their study evaluating the efficacy of AMY-101 in COVID-19 patients with ARDS.
read more
Wednesday, January 06, 2021
Quartesian has earned ISO 9001:2015 certification for its quality management system and the ISO/IEC 27001:2013 certification for its systems and processes for managing sensitive company information.
read more
Tuesday, October 20, 2020
Quantum Genomics has entered into an exclusive licensing and collaboration agreement with Qilu to develop and commercialize firibastat in Greater China region, Hong Kong and Macao.
read more
Thursday, December 03, 2020
Quantum Genomics has entered into an exclusive licensing and collaboration agreement with DongWha Pharm to develop and commercialize firibastat in the Republic of Korea.
read more
Tuesday, December 10, 2019
Quantum Genomics and Biolab Sanus have entered into an exclusive licensing and collaboration agreement to develop and commercialize firibastat in Latin America.
read more
Tuesday, December 29, 2020
Quantum Genomics has signed a strategic contract with Delpharm for the manufacture of the next clinical batches of firibastat tablets on an industrial scale and the establishment of production lines for future commercial batches.
read more
Monday, December 21, 2020
Quantum Genomics has entered into an exclusive licensing and collaboration agreement with Faran to develop and commercialize firibastat in Greece.
read more
Monday, November 02, 2020
Quantum Genomics has entered into an exclusive licensing and collaboration agreement with Xediton to develop and commercialize firibastat in Canada.
read more
Quantify Research (QUANTIFY) announced their expansion into Denmark and Norway to expand the breadth and depth of their Nordic service offerings. QUANTIFY is a global partner to the life science industry in the development of real-world evidence ...
read more
Tuesday, September 26, 2017
Quanticate is further expanding its service offering into India with the opening of a new office.
read more
Thursday, January 26, 2023
Quanticate, a global data-focused clinical research organisation (CRO), has announced the appointment of Yolanda Barbachano as Head of Statistics.
read more
Monday, November 20, 2017
Quanticate has launched its centralized statistical monitoring service as an extension of its statistical consultancy offering.
read more
Tuesday, January 15, 2019
Quanticate has launched QVigilance to provide dedicated pharmacovigilance (PV) and risk management services.
read more
Thursday, September 30, 2021
Quanticate, a leading global data-focused Clinical Research Organization (CRO), has named Nick Darbey as the company's Executive Vice President of Business Development.
read more
Quanticate, a leading global data-focused clinical research organization (CRO), has engineered a new Remote Source Data Verification (RSDV) Platform. The 21 CFR part 11 compliant cloud-based application allows verification of multiple clinical ...
read more